MALDI-MSI of Lipids in Human Skin

Fig. 1

MALDI-MS images of a cross section of untreated human skin (with the stratum corneum at the top of each image), acquired at a spatial resolution of 30 μm × 30 μm. Images labeled (b) (m/z 760) and (e) (m/z 939) have been normalized against the matrix peak, m/z 417 (c), and the images labeled (a) (m/z 760) and (d) (m/z 939) have not been normalized [18]

Acknowledgments

This work was supported by the Biomolecular Sciences Research Centre of Sheffield Hallam University.

References

Enthaler B, Pruns JK, Wessel S, Rapp C, Fischer M, Wittern KP (2012) Improved sample preparation for MALDI–MSI of endogenous compounds in skin tissue sections and mapping of exogenous active compounds subsequent to ex-vivo skin penetration. Anal Bioanal Chem 402(3):1159–1167CrossRefPubMed

Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RHH (2015) Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol 28:42–55CrossRefPubMed

Roy S, Touboul D, Brunelle A, Germain DP, Prognon P, Laprévote O, Chaminade P (2006) Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry’s disease. Ann Pharm Fr 64(5):328–334CrossRefPubMed

Doering T, Hollerans WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K (1999) Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 274(16):11038–11045CrossRefPubMed

Only gold members can continue reading. Log In or Register to continue